BiotechTube
Home/NysnoBio/Christina Gamba-Vitalo, PhD
CG

Christina Gamba-Vitalo, PhD

Head of in vivo Pharmacology and Toxicology

NysnoBio

Therapeutic Areas

Parkinson's DiseaseNeurodegenerative Diseases

NysnoBio Pipeline

DrugIndicationPhase
Gene Therapy for PARKIN-PDParkinson's Disease (Parkin mutation-associated)Preclinical

Leadership Team at NysnoBio

JA
Jennifer A. Johnston, PhD
Cofounder and CEO
DM
David M. Weiner, MD
Chief Medical Officer
EH
Elizabeth Higgins, PhD
Chief Technology Officer
RM
Ron Mandel, PhD
Head of Gene Therapy Programs
DG
David Giannini
Cofounder and Executive Chairman
View full NysnoBio profile